Tamoxifen synergizes the antiproliferative effect of cisplatin in human ovarian cancer cells: enhancement of DNA platination as a possible mechanism (Q60768392)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 November 1996

Language	Label	Description	Also known as
English	Tamoxifen synergizes the antiproliferative effect of cisplatin in human ovarian cancer cells: enhancement of DNA platination as a possible mechanism	scientific article published on 01 November 1996

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950203%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Tamoxifen synergizes the antiproliferative effect of cisplatin in human ovarian cancer cells: enhancement of DNA platination as a possible mechanism (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950203%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Rosa De Vincenzo

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950203%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Francesco Petrucci

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950203%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

A Ercoli

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950203%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

G Scambia

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950203%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

A Alimonti

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950203%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

A Fattorossi

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950203%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

G Isola

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950203%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

P Benedetti Panici

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950203%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

S Caroli

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950203%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

S Mancuso

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950203%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

language of work or name

0 references

publication date

1 November 1996

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950203%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950203%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

108

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950203%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950203%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

7-14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950203%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Synergistic antiproliferative activity of tamoxifen and cisplatin on primary ovarian tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904371-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Tamoxifen: is it useful in the treatment of patients with metastatic melanoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904371-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Tamoxifen in combination with cytotoxic chemotherapy in advanced epithelial ovarian cancer. A prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904371-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II trial investigating primary immunochemotherapy for malignant pleural mesothelioma and the feasibility of adjuvant immunochemotherapy after maximal cytoreduction

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904371-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Type-II estrogen binding sites in a lymphoblastoid cell line and growth-inhibitory effect of estrogen, anti-estrogen and bioflavonoids

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904371-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-oestrogens induce the secretion of active transforming growth factor beta from human fetal fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904371-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Interaction of tamoxifen with cytosolic and nuclear type II estrogen binding sites (type II EBS).

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904371-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Criteria for analyzing interactions between biologically active agents

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904371-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhancement of antiproliferative effect of cis-diamminedichloroplatinum(II) by clomiphene and tamoxifen in human ovarian cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904371-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Ovarian carcinoma cells in culture: assessment of drug sensitivity by clonogenic assay

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904371-6

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro evaluation of anticancer drugs in relation to development of drug resistance in the human tumor clonogenic assay.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904371-6

7 January 2021

based on heuristic

inferred from DOI database lookup

cis-platinum and ovarian carcinoma. In vitro chemosensitivity of cultured tumour cells from patients receiving high dose cis-platinum as first line treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904371-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular heterogeneity and drug resistance in two ovarian adenocarcinoma cell lines derived from a single patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904371-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Tamoxifen delays the development of resistance to cisplatin in human melanoma and ovarian cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904371-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0304-3835(96)04371-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950203%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8950203%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q60768392&oldid=1962236324"